|
1) Khau Van Kien P, Mathieu F, Zhu L, et al. Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12. 2-p13. 13. Circulation. 2005; 112: 200-6
|
|
|
|
2) Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970; 26: 72-83
|
|
|
|
|
|
3) McKusick VA. Association of congenital bicuspid aortic valve and Erdheimʼs cystic medial necrosis. Lancet. 1972; 1: 1026-7
|
|
|
|
|
|
4) Roberts CS, Roberts WC. Dissection of the aorta associated with congenital malformation of the aortic valve. J Am Coll Cardiol. 1991; 17: 712-6
|
|
|
|
|
|
5) Harn RT, Roman MJ, Mogtader AH, et al. Association of aortic dilation with regurgitation, stenotic and functionally normal aortic valves. J Am Coll Cardiol. 1992; 19: 283-8
|
|
|
|
|
|
6) David TE, Omran A, Ivanov J, et al. Dilatation of the pulmonary autograft after the Ross proce-dure. J Thorac Cardiovasc Surg. 2000; 119: 210-20
|
|
|
|
|
|
7) de SA M, Moshkovitz Y, Butany J, et al. Histological abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: Clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg. 1999; 118: 588-96
|
|
|
|
|
|
8) Chong WY, Wong WH, Chiu CS, et al. Aortic root dilatation and aortic elastic properties in children after repair of tetralogy of Fallot. Am J Cardiol. 2006; 97: 905-9
|
|
|
|
|
|
9) Cheung YF, Wong SJ. Central and peripheral arterial stiffness in patients after surgical repair of tetralogy of Fallot: implication for aortic root dilatation. Heart. 2006; 92: 1827-30
|
|
|
|
|
|
10) Senzaki H, Iwamoto Y, Ishido H, et al. Arterial haemodynamics in patients after repair of tetralogy of Fallot: influence on left ventricular after load and aortic dilatation. Heart. 2008; 94: 70-4
|
|
|
|
|
|
11) Niwa K, Perloff JK, Bhuta SM, et al. Structural abnormalities of great arterial walls in congenital heart disease. Light and electron microscopic analyses. Circulation. 2001; 103: 393-400
|
|
|
|
|
|
12) Isner JM, Donaldson RF, Fulton D, et al. Cystic medial necrosis in coarctation of the aorta. Circulation. 1987; 75: 689-95
|
|
|
|
|
|
13) Schaefer BM, Lewin MB, Stout KK, et al. Usefulness of bicuspid aortic valve phenotype to predict elastic properties of the ascending aorta. Am J Cardiol. 2007; 99: 686-90
|
|
|
|
|
|
14) Niwa K, Siu S, Webb G, et al. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation. 2002; 106: 1374-78
|
|
|
|
|
|
15) Tan Jl, Davlouros PA, Mccaethy KP, et al. Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilatation and aortopathy. Circulation. 2005; 112: 961-8
|
|
|
|
|
|
16) Cheung YF, Wong SJ. Central and peripheral arterial stiffness in patients after surgical repair of tetralogy of Fallot: implication for aortic root dilatation. Heart. 2006; 92: 1827-30
|
|
|
|
|
|
17) Dodds III GA, Warnes CA, Danielson GK. Aortic valve replacement after repair of pulmonary atresia and ventricular septal defect or tetralogy of Fallot. J Thorac Cardiovasc Surg. 1997; 113: 736-41
|
|
|
|
|
|
18) Kim WH, Seo JW, Kim SJ, et al. Aortic dissection late after repair of tetralogy of Fallot. Int J Cardiol. 2005; 101: 515-6
|
|
|
|
|
|
19) Rathi VK, Doyle M, Williams RB, et al. Massive aortic aneurysm and dissection in repaired tetralogy of Fallot; Diagnosis by cardiovascular magenetic resonance imaging. Int J Cardiol. 2005; 101: 169-70
|
|
|
|
|
|
20) Konstantinov IE, Fricke TA, dʼUdekem Y, et al. Aortic dissection and rupture in adolescents after tetralogy of Fallot repair. J Thorac Cardiovasc Surg. 2010; 140: e71-3
|
|
|
|
|
|
21) Chugh R, Child J, Perloff JK, et al. Echo-cardiographic characterization of the aortic root in adults with tetralogy of Fallot. Circulation. 2001; 104: II-558
|
|
|
|
|
|
22) 坂崎尚徳, 鈴木嗣敏, 槇野征一郎, 他. ファロー四徴症根治術後遠隔期の大動脈弁閉鎖不全の検討. 日小循誌. 2002; 18: 13-8
|
|
|
|
|
|
23) Chowdhury UK, Mishra AK, Balakrishnan P, et al. Role of fibrillin-1 genetic mutations and polymorphism in aortic dilatation in patients undergoing intracardiac repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2008; 136: 757-66
|
|
|
|
|
|
24) 竹内敬昌. 一期的 Jatene 手術症例における大動脈及び肺動脈基部中膜の組織学的検討. 日児循誌. 1996; 12: 506-12
|
|
|
|
|
|
25) Marino BS, Wernovsky G, McElhinney DB, et al. Neo-aortic valvar function after the arterial switch. Cardiol Young. 2006; 16: 481-9
|
|
|
|
|
|
26) Losay J, Touchot A, Capderou A, et al. Aortic valve regurgitation after arterial switch operation for transposition of the great arteries: incidence, risk factors, and outcome. J Am Coll Cardiol. 2006; 47: 2057-62
|
|
|
|
|
|
27) Roman MJ, Devereux RB, Niles NW, et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989; 64: 507-12
|
|
|
|
|
|
28) Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfanʼs syn-drome. N Engl J Med. 1994; 330: 1335-41
|
|
|
|
|
|
29) Gersony DR, McClaughlin MA, Jin Z, et al. The effect of beta-blocker therapy on clinical outcome. Int J Cardiol. 2007; 114: 303-8
|
|
|
|
|
|
30) Engelfriet P, Mulder B. Is there benefit of beta-blocking agents in the treatment of patients with the Marfan syndrome？ Int J Cardiol. 2007; 114: 300-2
|
|
|
|
|
|
31) Nollen GJ, westerhof BE, Groenink M, et al. Aortic pressure-area relation in Marfan patients with and without beta blocking agents: a new non-invasive approach. Heart. 2004; 90: 314-8
|
|
|
|
|
|
32) Ladouceur M, fermanian C, Lupoglazoff JM, et al. Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am J Cardiol. 2007; 99: 406-9
|
|
|
|
|
|
33) Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006; 312: 117-21
|
|
|
|
|
|
34) Brooke BS, Habashi JP, Judge DP, et al. Angiotensin II blockade and aortic-root dilation in Marfanʼs syndrome. N Engl J Med. 2008; 358: 2787-95
|
|
|
|
|
|
35) Lacro RV, Dietz HC, Wruck LM, et al. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J. 2007; 154: 624-31
|
|
|
|
|
|
36) David TE, Omran A, Ivanov J, et al. Dilatation of the pulmonary autograft after the Ross proce-dure. J Thorac Cardiovasc Surg. 2000; 119: 210-20
|
|
|
|
|
|
37) de SA M, Moshkovitz Y, Butany J, et al. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg. 1999; 118: 588-94
|
|
|
|
|
|
38) Therrien J, Gatzoulis M, Graham T, et al. CCS Consensus Conference 2001 update: Recommen-dations for the Management of Adults with Con-genital Heart Disease - Part II. Can J Cardiol. 2001; 17: 1029-50
|
|
|
|
|
|
39) Stulak JM, Dearani JA, Burkhart HM, et al. Does the dilated ascending aorta in an adult with congenital heart disease require intervention？ J Thorac Cardiovasc Surg. 2010; 140(6 Suppl): S52-7
|
|
|
|
|
|
40) Cohen MS, Marino BS, McElhinney DB, et al. Neo-aortic root dilatation and valve regurgitation up to 21 years after staged reconstruction for hypoplastic left heart syndrome. J Am Coll Cardiol. 2003; 42: 533-40
|
|
|
|
|
|
41) Schawrtz ML, Gauvreau K, del Nido P, et al. Long term predictors of aortic root dilatation and aortic regurgitation after arterial switch operation. Circulation. 2004; 110(11 Suppl 1): II 128-32
|
|
|
|
|
|
42) Egan M, Phillips A, Cook SC. Aortic dissection in the adult Fontan with aortic root enlargement. Pediatr Cardiol. 2009; 30: 562-3
|
|
|
|
|